These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30353794)

  • 1. The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.
    McLaren JL; Lichtenstein JD
    Epidemiol Psychiatr Sci; 2019 Aug; 28(4):365-368. PubMed ID: 30353794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis.
    Barrett BF; Wehmeyer M; Kolb J; Ostermann T; Sappok T
    J Intellect Disabil Res; 2024 Aug; 68(8):941-953. PubMed ID: 38545626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities.
    McConkey R; Samadi SA; Mahmoodizadeh A; Taggart L
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to antihypertensive medication adherence among adults with intellectual and developmental disability.
    Resciniti NV; Hong Y; McDermott S
    J Intellect Disabil; 2022 Mar; 26(1):137-148. PubMed ID: 33140659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
    Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
    J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of psychotropic medications in children with developmental disabilities.
    Calles JL
    Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk psychotropic medications for US children with trauma sequelae.
    Barnett ER; Concepcion Zayas MT
    Epidemiol Psychiatr Sci; 2019 Aug; 28(4):360-364. PubMed ID: 30392479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England.
    Branford D; Sun JJ; Shankar R
    Br J Psychiatry; 2023 May; 222(5):191-195. PubMed ID: 36786124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do people with intellectual disabilities, their family members and paid carers understand about psychotropic medication? A rapid review.
    Cavanagh DE; Caton S; Rawles J; Runswick-Cole K; Hatton C; Chauhan U; Hutchinson C
    J Appl Res Intellect Disabil; 2024 Sep; 37(5):e13283. PubMed ID: 39039824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution.
    Kelly S; Su Y
    Intellect Dev Disabil; 2015 Aug; 53(4):289-300. PubMed ID: 26214558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.